Results 121 to 130 of about 1,796,626 (255)

Tellurium-118 as a novel radionuclide for long-term positron emission tomography

Scientific Reports
Positron emission tomography (PET) is a powerful imaging modality that tracks positron-emitting radionuclides, enabling non-invasive and high-resolution visualization of biological targets and processes.
Sotaro Miyao, Toshimitsu Momose, Masako Kawabata, Yuki Mitsuya, Atsuko Nakanishi Ozeki, Arisa Hayashi, Xindi Qiu, Yousuke Kanayama, Hiromitsu Haba, Izumi O. Umeda, Jaewoong Jang, Youichiro Wada, Nobuyoshi Akimitsu, Hiroyuki Takahashi   +13 more
doaj   +1 more source

Systematic review and meta-analysis of the diagnostic value of radionuclide imaging for thyroid nodules. [PDF]

Gland Surg, 2021
Song X, Luo Z, Sun H, Hao L.
europepmc   +1 more source

Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single‐Arm Phase II Study

Cancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Merkel Cell Carcinoma (MCC) is a rare, aggressive neuroendocrine and epithelial skin cancer. Somatostatin analogues, such as lanreotide, have shown efficacy in managing other neuroendocrine tumors. Retrospective studies suggest that lanreotide may induce partial response or disease stabilization in patients with advanced MCC.
Julie Charles, Aude Belbezier, Stéphane Mouret, Brigitte Dreno, Stéphane Dalle, Céleste Lebbe, Ewa Hainaut‐Wierzbicka, Andreea Stefan, Julie de Quatrebarbes, Olivier Dereure, Ouidad Zehou, Sandrine Mansard, Alain Dupuy, Caroline Dutriaux, Florent Grange, Caroline Gaudy‐Marqueste, Henri Montaudié, Jean‐Philippe Arnault, Yannick Le Corre, Thibault Kervarrec, Jean‐Louis Quesada, Mahtab Samimi, Marie‐Thérèse Leccia, The Group of Cutaneous Oncology of the French Society of Dermatology   +23 more
wiley   +1 more source

Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with ^99mTc for Radionuclide Imaging of HER2 Expression in Cancer. [PDF]

Int J Mol Sci, 2022
Larkina M, Plotnikov E, Bezverkhniaia E, Shabanova Y, Tretyakova M, Yuldasheva F, Zelchan R, Schulga A, Konovalova E, Vorobyeva A, Garousi J, Gräslund T, Belousov M, Tolmachev V, Deyev S.   +14 more
europepmc   +1 more source

Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment

, 2011
Radiolabeled peptides have been an important class of compounds in radiopharmaceutical sciences and nuclear medicine for more than 20 years. Despite strong research efforts, only somatostatin-based radiopeptides have a real impact on patient care ...
Helmut R. Maecke, Jean Claude Reubi, Maecke, Helmut R, Reubi, Jean-Claude   +3 more
core   +1 more source

Gastric Emptying in Obesity and Weight‐Loss Interventions: Physiology, Assessment, and Clinical Implications

Comprehensive Physiology, Volume 16, Issue 5, October 2026.
Obesity is associated with accelerated gastric emptying. Weight‐loss interventions each impose a distinct emptying signature: acceleration after sleeve gastrectomy and gastric bypass, delay after endoscopic sleeve gastroplasty, intragastric balloon, and GLP‐1 receptor agonists.
Maxime Amoyel, Rachida Lebtahi, Tigran Poghosyan, Maude Le Gall, Heithem Soliman   +4 more
wiley   +1 more source

Optimization of radiation protection in radionuclide therapy: Proposals for developing quality assurance programs

Радиационная гигиена
In order to ensure a high-quality and safe therapeutic process in radionuclide therapy, it is not sufficient to rely solely on safety monitoring within the framework of production control. Measures must be implemented within a quality assurance system as
A. V. Likhacheva, A. V. Vodovatov, L. A. Chipiga   +2 more
doaj   +1 more source

Radionuclide Imaging of Fungal Infections and Correlation with the Host Defense Response. [PDF]

J Fungi (Basel), 2021
Ankrah AO, Sathekge MM, Dierckx RAJO, Glaudemans AWJM.   +3 more
europepmc   +1 more source

Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy

, 2015
Radionuclide therapy aims to treat malignant diseases by systemic administration of radiopharmaceuticals, often using carrier molecules such as peptides and antibodies.
Sjögreen Gleisner, Katarina, Katarina Gleisner, Ljungberg, Michael, Michael Ljungberg, Katarina Sjögreen Gleisner   +4 more
core   +1 more source

Targeting the DNA Damage Response in Cancer

MedComm, Volume 7, Issue 10, October 2026.
Targeting the DNA damage response (DDR) reshapes both tumor vulnerability and antitumor immunity. DNA lesions and DDR inhibitors can promote cytosolic nucleic‐acid sensing, antigen presentation, and immune activation, but can also induce adaptive immune escape.
Yihuan Qiao, Boyu Kang, Jian Zhang, Rui Zhang, Jipeng Li   +4 more
wiley   +1 more source